Xhosa
English French German Portuguese Spanish Russian Japanese Korean Arabic Irish Greek Turkish Italian Danish Romanian Indonesian Czech Afrikaans Swedish Polish Basque Catalan Esperanto Hindi Lao Albanian Amharic Armenian Azerbaijani Belarusian Bengali Bosnian Bulgarian Cebuano Chichewa Corsican Croatian Dutch Estonian Filipino Finnish Frisian Galician Georgian Gujarati Haitian Hausa Hawaiian Hebrew Hmong Hungarian Icelandic Igbo Javanese Kannada Kazakh Khmer Kurdish Kyrgyz Latin Latvian Lithuanian Luxembou.. Macedonian Malagasy Malay Malayalam Maltese Maori Marathi Mongolian Burmese Nepali Norwegian Pashto Persian Punjabi Serbian Sesotho Sinhala Slovak Slovenian Somali Samoan Scots Gaelic Shona Sindhi Sundanese Swahili Tajik Tamil Telugu Thai Ukrainian Urdu Uzbek Vietnamese Welsh Xhosa Yiddish Yoruba Zulu Kinyarwanda Tatar Oriya Turkmen Uyghur
Leave Your Message
Iintlobo zeemveliso
iveliso ezifakiwe
Iipilisi zeLenopril ezixhobisa uLawulo lweGazi kunye nempilo ye-Cardiovascular Health

Iipilisi zeLenopril ezixhobisa uLawulo lweGazi kunye nempilo ye-Cardiovascular Health
I-Telmisartan Ingcono i-antihypertensive Ukukhusela izintso

I-Telmisartan Ingcono i-antihypertensive Ukukhusela izintso
I-Flumazenil I-Antagonist ekhethiweyo ye-GABAA ye-Receptor kunye nezicelo zayo zonyango

I-Flumazenil I-Antagonist ekhethiweyo ye-GABAA ye-Receptor kunye nezicelo zayo zonyango
I-Trametinib Kinase Inhibitor Ijolise kwi-BRAF V600 yoGuquko-Positive Cancers

I-Trametinib Kinase Inhibitor Ijolise kwi-BRAF V600 yoGuquko-Positive Cancers
I-Dabrafenib Unyango olujolisiweyo lwe-BRAF-Mutated Cancers

I-Dabrafenib Unyango olujolisiweyo lwe-BRAF-Mutated Cancers
I-Tirzepatide Dual GLP-1 kunye ne-GIP Receptor Agonist yoLawulo lobunzima kunye noLawulo lweGlycemic

I-Tirzepatide Dual GLP-1 kunye ne-GIP Receptor Agonist yoLawulo lobunzima kunye noLawulo lweGlycemic
Cisapride Gastric Stimulant for Indigestion and Digestive Disorders

Cisapride Gastric Stimulant for Indigestion and Digestive Disorders
I-YK-11 ye-SARM enamandla kwiZakhiwo zeMuscle, iiNgeniso zamandla, kunye ne-Myostatin Inhibition

I-YK-11 ye-SARM enamandla kwiZakhiwo zeMuscle, iiNgeniso zamandla, kunye ne-Myostatin Inhibition
I-Ostarine (MK-2866) i-SARM eNqabileyo yokuKhula kweMuscle, ukuLahla kwaManqatha, kunye nokuBuyiswa koMzimba

I-Ostarine (MK-2866) i-SARM eNqabileyo yokuKhula kweMuscle, ukuLahla kwaManqatha, kunye nokuBuyiswa koMzimba
I-MK-677 i-Compound ekhethekileyo yokuKhula kweZihlunu, ukunyamezela, kunye nokuBuyisa

I-MK-677 i-Compound ekhethekileyo yokuKhula kweZihlunu, ukunyamezela, kunye nokuBuyisa
0102030405
ILeuprorelin Hormone Therapy yeProstate kunye noMhlaza wamabele
ILeuprorelin Hormone Therapy yeProstate kunye noMhlaza wamabele
ILeuprorelin Hormone Therapy yeProstate kunye noMhlaza wamabele

ILeuprorelin Hormone Therapy yeProstate kunye noMhlaza wamabele

ixabiso Reference: USD 30-100

  • Igama lemveliso Leuprorelin
  • Inombolo yeCAS. 53714-56-0
  • Ukuxinana 1.44
  • Indawo yokunyibilika 150-155°C
  • Indawo yokubilisa I-1720.5 ° C kwi-760 mmHg
  • MF I-C59H84N16O12
  • MW 1269.473
  • Isalathiso sokuqhafaza 1.681
  • Indawo yokuflasha 994.3°C
Qhagamshelana nathi
iinkcukacha zemveliso

Inkcazo eneenkcukacha

I-Leuprorelin, eyaziwa ngokuba yi-Lupron okanye i-Prostap, lunyango lwe-hormone olusetyenziswa kunyango lwe-prostate kunye nomhlaza webele. Kukwiklasi yamayeza abizwa ngokuba yi-gonadotropin-releasing hormone (GnRH) agonists. Kwesi sincoko, siya kugxila ekusetyenzisweni kwayo kwi-prostate kunye nonyango lomhlaza wamabele.

Unyango lweProstate Cancer:
ILeuprorelin iqhele ukusetyenziselwa ukunyanga umhlaza wedlala lesinyi. Isebenza ngokunciphisa izinga le testosterone eveliswa ngamasende. Iiseli zomhlaza wedlala lobudoda zixhomekeke kwi-testosterone ekukhuleni, ngoko ke ukunciphisa amanqanaba awo kunokunciphisa umhlaza okanye kucothise ukukhula kwawo. Ulawulo lwe-leuprorelin lunceda ukulawula iimpawu ezinxulumene nomhlaza wedlala lesinyi kunye nokuphucula umgangatho wobomi besigulana.

Unyango loMhlaza wamabele:
I-Leuprorelin ikwasetyenziswa kunyango lweentlobo ezithile zomhlaza wamabele. Isetyenziswe ngokukodwa kwiimeko apho iiseli zomhlaza zine-estrogen receptors (ER positive) kwaye isigulane asizange sidlule kwi-menopause. I-Leuprorelin inciphisa izinga le-estrogen emzimbeni ngokucinezela ukuveliswa kwayo kwii-ovari. Oku kubalulekile kuba amanqanaba aphezulu e-estrogen anokukhuthaza ukukhula kweeseli zomhlaza wamabele. I-Leuprorelin inokulawulwa yodwa okanye idityaniswe nolunye unyango lwe-hormone ukulawula ngokufanelekileyo umhlaza webele.


1713519263878x41

Embindini Phantse Ukufikisa:

Inaliti ye-Leuprorelin, eyaziwa ngokuba yi-Lupron Depot-PED, isetyenziswa kubantwana abaneminyaka eyi-2 nangaphezulu ukunyanga i-central precocious puberty (CPP). I-CPP yimeko apho amantombazana (ahlala engaphantsi kweminyaka eyi-8) kunye namakhwenkwe (ahlala engaphantsi kwe-9 yeminyaka ubudala) angena ebusheni ngaphambi kwexesha. I-Leuprorelin inceda ukulawula ixesha lokufikisa ngokunciphisa ukukhula kwamathambo okukhawuleza kunye nokuphuhliswa kweempawu zesondo ezinxulumene ne-CPP.


Olunye Usetyenziso Lweklinikhi:

Inaliti yeLeuprorelin, ekwabizwa ngokuba yiLupron Depot, isetyenziswa kunyango lwe-endometriosis kunye ne-anemia ebangelwa yi-uterine fibroids. Isebenza ngokunciphisa amanqanaba eehomoni ezithile emzimbeni, ukunika isiqabu kwiimpawu ezinje ngeentlungu, ukuya exesheni okunzima okanye okungaqhelekanga, kunye ne-anemia. Ukongeza, i-leuprorelin inokusetyenziswa njengonyango lwangaphambili lwezonyango ngaphambi kokuhlinzwa kwe-endometrial, njengoko inciphisa i-endometrium, inciphisa i-edema, kwaye iququzelele inkqubo yotyando.


Pharmacokinetics:
I-Leuprorelin acetate ayisebenzi xa ithathwa ngomlomo kwaye endaweni yoko ilawulwa nge-subcutaneous okanye intramuscular injection. Ukulandela i-injection enye ye-subcutaneous ye-3.75 mg, i-concentration ye-plasma ephezulu ifikeleleke phakathi kwe-1 kwiintsuku ze-2, kunye namanqanaba e-1 ukuya kwi-2 ng / ml. Kunyango lomhlaza wesifo seprotate, i-injection subcutaneous ye-3.75 mg inikezelwa zonke iiveki ze-4 kwii-injection ezipheleleyo ze-3 ukuphumeza ugxininiso lwe-plasma oluzinzileyo lwe-0.1 ukuya kwi-1 ng / ml. I-Leuprorelin i-metabolized ibe ziimveliso ezine zokuthotywa emzimbeni kwaye ikhutshwe ngokuyintloko ngezintso.

1713519136575m79LEUPk8x


Isiphelo:
I-Leuprorelin, iGnRH agonist, lunyango oluxabisekileyo lwehomoni olusetyenziswa kunyango lwedlala lengqula kunye nomhlaza wamabele, kunye nombindi wokufikisa, i-endometriosis, kunye ne-anemia ebangelwa yi-uterine fibroids. Ngokunciphisa amanqanaba e-testosterone okanye e-estrogen, i-leuprorelin inceda ukulawula ukukhula kunye neempawu ezinxulumene nezi meko. Ukulawulwa kwe-leuprorelin kufuna ukujongwa kwezonyango kunye nokubeka iliso rhoqo ukuze kuqinisekiswe ukusebenza kwayo kunye nokulawula nayiphi na imiphumo enokubakho.

Khumbula ukunxibelelana nathi malunga nokupakishwa okuneenkcukacha kunye neefomu zokuthumela, siya kubonelela ngeenkonzo zokwenza ngokwezifiso ze-OEM/ODM.

Inkcazo

1713518948172cpi